Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet and Commencement of Subsequent Offering

by Matthew Kennedy, Benzinga Staff Writer
March 2, 2012 8:01 AM | 16 seconds read |
Amgen ("Amgen") AMGN announced today that all conditions to the closing of the tender offer by a  wholly owned subsidiary, "Merger Sub", to acquire all outstanding shares of common stock of Micromet, Inc. MITI for $11.00 per share in cash have been satisfied. 
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsM&A
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!